Sandoz granted tentative approval for generic of Pfizer's Inlyta
Source: SeekingAlpha
2025-10-10 11:07:52 ET
More on Pfizer
- Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview)
- Pfizer: Mastering The Art Of The Deal With Metsera - Upgraded To Buy
- Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers
- Dividend Roundup: Lockheed Martin, Pfizer, Genpact, Delta Air Lines, and more
- Next CDC AdCom meeting on vaccines delayed
Read the full article on Seeking Alpha
For further details see:
Sandoz granted tentative approval for generic of Pfizer's Inlyta
Sandoz Group Ag Shs
NASDAQ: SDZXF
SDZXF Trading
0.0% G/L:
$88 Last:
611 Volume:
$88 Open:
